NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor investors who were...
Related Questions
How likely is a settlement or judgment before the September 15, 2025 lead plaintiff deadline, and what are the potential financial impacts?
What has been the historical market reaction to similar class action lawsuits for biotech firms, and how might CAPR's stock volatility be affected?
Will this litigation affect Capricor's ability to secure financing, continue R&D projects, or meet upcoming regulatory milestones?